| abstract |
Disclosed are imidazole compounds represented by formula (B), or pharmaceutically acceptable salts thereof. Also disclosed is the use of the compounds of formula (B) in the preparation of a medicament for treating a microsomal E synthase-1 mediated disease or condition such as acute or chronic pain, osteoarthritis, rheumatoid arthritis, bursitis, ankylosing sponylitis and primary dysmenorrhea. |